Risk minimization measures

Scientific Name Brand name Approval Date Last Update Details
Voriconazole Vultera View
Carfilzomib  Kyprolis  View
Tocilizumab Actemra View
Upadacitinib Rinvoq  View
Montelukast Montelukast View
Methotrexate Methotrexate Ebewe View
Teriparatide Bonteo  View
Daratumumab Darzalex View
Alemtuzumab Lemtrada  View
Tofacitinib Xeljanz  View